- Discover how you can be a part of medical product approvals.
- View the August 17, 2016 Patient Network Newsletter
- See how the FDA is working with patients
- Find information about FDA’s expanded access policies and requirements for enrolling in expanded access programs
Navigate the For Patients Section
Find information about the Office of Health and Constituent Affairs, Patient Liaison Program. You can also listen to webinar's offered by FDA experts.Calendar of Public Meetings
Participate or find information on an upcoming FDA sponsored workshop, conference or advisory committee meeting.Comment on Current FDA Draft Guidances
Read FDA Federal Register Notices and submit your comments on current FDA draft guidances and other policy related questions that affect patients and caregivers.Get Illness/Condition Information
FDA brings the patient perspective into the review of medical products that treat Cancer, Cardiovascular disease, Diabetes, Hepatitis B & C, HIV/AIDS and other illnesses.
Clinical trials, informed consent and FDA's role in ensuring that people of different demographics are included in clinical trials (FDASIA section 907).Learn About Drug and Device Approvals
FDA is speeding up the approval process for Drugs and Medical Devices. Learn how medical products are approved.Learn About Other Treatment Options
Expanded access, investigational new drugs and off-label use of approved products.Learn About Patient Engagement at the FDA
Learn about the FDA Patient Representative Program and discover other ways that patients and caregivers are working with the FDA to have their voice included in medical product approvals and FDA policy.
FDA Patient Specific E-mail List serves
- FDA's Patient Network Newsletter
Sign Up for our bi-weekly email newsletter that provides information about product safety, drug shortages, product approvals, upcoming meetings, and more.
Updates on safety and regulatory issues related to Cardiovascular Disease, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
- FDA Diabetes Monitor
Updates on safety and regulatory issues related to Diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
Hepatitis B and C Updates
Late breaking information, as well as an archival record of updates on safety and regulatory issues related to Hepatitis B and C
Updates on important safety and regulatory issues related to HIV, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
FDA Office of Minority Health Email Updates
Updates on health and safety information that are important to minority communities, and a quarterly newsletter detailing upcoming issues and opportunities for you to inform future directions in research.
Subscribe to MedWatch Safety Aletrts
Safety alerts delivered to your inbox. To subscribe, just provide your e-mail address. E-list managed by GovDelivery.
- August 29, 2016 - Public Workshop: Diabetes Outcome Measures Beyond Hemoglobin A1c
- September 27, 2016 - Patient Focused Drug Development: Patients Who Have Received an Organ Transplant
- September 30, 2016 -Public Workshop:Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices, September 30, 2016